The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Treatment interruptions predict resistance in HIV-positive individuals purchasing fixed-dose combination antiretroviral therapy in Kampala, Uganda
Abstract
OBJECTIVE: To evaluate adherence, treatment interruptions, and outcomes in patients purchasing antiretroviral fixed-dose combination (FDC) therapy. DESIGN: Ninety-seven participants were recruited into a prospective 24-week observational cohort study of HIV-positive, antiretroviral-naive individuals initiating self-pay Triomune or Maxivir therapy in Kampala, Uganda. Adherence was measured by monthly structured interview, unannounced home pill count, and electronic medication monitors (EMM). Treatment interruptions were measured as continuous intervals greater than 48 h without opening the EMM. The primary outcomes were survival with viral suppression below 400 copies/ml, CD4 cell increases, and genotypic drug resistance at 24 weeks. RESULTS: The median baseline CD4 cell count was 56 cells/microl and median log10 copies RNA/ml was 5.54; mean adherence ranged from 82 to 95% for all measures but declined significantly over time. In an intent-to-treat analysis, 70 (72%) patients had an undetectable plasma HIV-RNA level at week 24. Sixty-two of 95 (65%) individuals with continuous EMM data had a treatment interruption of greater than 48 h. Treatment interruptions accounted for 90% of missed doses. None of 33 participants who did not interrupt treatment for over 48 h had drug resistance, whereas eight of 62 (13%) participants who did interrupt therapy experienced drug resistance. Antiretroviral resistance was seen in 8% of individuals and overall mortality was 10% at 24 weeks. CONCLUSION: HIV-positive individuals purchasing generic FDC antiretroviral therapy have high rates of adherence and viral suppression, low rates of antiretroviral resistance, and robust CD4 cell responses. Adherence is an important predictor of survival with full viral suppression. Treatment interruptions are an important predictor of drug resistance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
An inventory for measuring depression
BECK, A. T. (1961) · Archives of General Psychiatry · doi:10.1001/archpsyc.1961.01710120031004 · Cited by 38,032
SAUNDERS, J. B., AASLAND, O. G., BABOR, T. F., DE LA FUENTE, J. R., & GRANT, M. (1993) · Addiction · doi:10.1111/j.1360-0443.1993.tb02093.x · Cited by 13,597
Adherence to Protease Inhibitor Therapy and Outcomes in Patients with HIV Infection
Paterson, D. L., Swindells, S., Mohr, J., Brester, M., Vergis, E. N., Squier, C., Wagener, M. M., & Singh, N. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-133-1-200007040-00004 · Cited by 3,289
On the Validity of the Beck Depression Inventory
Richter, P., Werner, J., Heerlein, A., Kraus, A., & Sauer, H. (1998) · Psychopathology · doi:10.1159/000066239 · Cited by 1,113
Human Immunodeficiency Virus Reverse Transcriptase and Protease Sequence Database
Shafer, R. W., Stevenson, D., & Chan, B. (1999) · Nucleic Acids Research · doi:10.1093/nar/27.1.348 · Cited by 907
Adherence to Antiretroviral Therapy in Sub-Saharan Africa and North America: A Meta-analysis
Mills, E. J., Nachega, J. B., Buchan, I., Orbinski, J., Attaran, A., Singh, S., Rachlis, B., Wu, P., Cooper, C., Thabane, L., et al. (2006) · JAMA · doi:10.1001/jama.296.6.679 · Cited by 899
Self-citationMills, E. J., Nachega, J. B., Bangsberg, D. R., Singh, S., Rachlis, B., Wu, P., Wilson, K., Buchan, I., Gill, C. J., & Cooper, C. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030438 · Cited by 818
Self-citationHuman immunodeficiency virus reverse transcriptase and protease sequence database
Rhee, S.-Y. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg100 · Cited by 817
A Comparison Study of Multiple Measures of Adherence to HIV Protease Inhibitors
Liu, H., Golin, C. E., Miller, L. G., Hays, R. D., Beck, C. K., Sanandaji, S., Christian, J., Maldonado, T., Duran, D., Kaplan, A. H., et al. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-134-10-200105150-00011 · Cited by 758
Arnsten, J. H., Demas, P. A., Farzadegan, H., Grant, R. W., Gourevitch, M. N., Chang, C., Buono, D., Eckholdt, H., Howard, A. A., & Schoenbaum, E. E. (2001) · Clinical Infectious Diseases · doi:10.1086/323201 · Cited by 637
Bangsberg, D. R. (2006) · Clinical Infectious Diseases · doi:10.1086/507526 · Cited by 534
Self-citationDevelopment and validation of a self-completed HIV symptom index
Justice, A. C., Holmes, W., Gifford, A. L., Rabeneck, L., Zackin, R., Sinclair, G., Weissman, S., Neidig, J., Marcus, C., Chesney, M., et al. (2001) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(01)00449-8 · Cited by 439
Adherence is not a barrier to successful antiretroviral therapy in South Africa
Orrell, C., Bangsberg, D. R., Badri, M., & Wood, R. (2003) · AIDS · doi:10.1097/00002030-200306130-00011 · Cited by 341
Self-citationLaurent, C., Kouanfack, C., Koulla-Shiro, S., Nkoué, N., Bourgeois, A., Calmy, A., Lactuock, B., Nzeusseu, V., Mougnutou, R., Peytavin, G., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16586-0 · Cited by 309
Oyugi, J. H., Byakika-Tusiime, J., Charlebois, E. D., Kityo, C., Mugerwa, R., Mugyenyi, P., & Bangsberg, D. R. (2004) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00126334-200408150-00014 · Cited by 282
Self-citationKlein, K., Lang, T., Saussele, T., Barbosa-Sicard, E., Schunck, W.-H., Eichelbaum, M., Schwab, M., & Zanger, U. M. (2005) · Pharmacogenetics and Genomics · doi:10.1097/01213011-200512000-00004 · Cited by 269
Haas, D. W., Smeaton, L. M., Shafer, R. W., Robbins, G. K., Morse, G. D., Labbé, L., Wilkinson, G. R., Clifford, D. B., D’Aquila, R. T., De Gruttola, V., et al. (2005) · The Journal of Infectious Diseases · doi:10.1086/497610 · Cited by 257
Parienti, J.-J., Massari, V., Descamps, D., Vabret, A., Bouvet, E., Larouze, B., & Verdon, R. (2004) · Clinical Infectious Diseases · doi:10.1086/383572 · Cited by 226
Maggiolo, F., Ravasio, L., Ripamonti, D., Gregis, G., Quinzan, G., Arici, C., Airoldi, M., & Suter, F. (2005) · Clinical Infectious Diseases · doi:10.1086/426595 · Cited by 224
Ribaudo, H. J., Haas, D. W., Tierney, C., Kim, R. B., Wilkinson, G. R., Gulick, R. M., Clifford, D. B., Marzolini, C., Fletcher, C. V., Tashima, K. T., et al. (2006) · Clinical Infectious Diseases · doi:10.1086/499364 · Cited by 221
Adherence to HIV antiretroviral therapy in HIV+ Ugandan patients purchasing therapy
Byakika-Tusiime, J., Oyugi, J. H., Tumwikirize, W. A., Katabira, E. T., Mugyenyi, P. N., & Bangsberg, D. R. (2005) · International Journal of STD & AIDS · doi:10.1258/0956462052932548 · Cited by 199
Self-citationLong-Term Benefits of Highly Active Antiretroviral Therapy in Senegalese HIV-1-Infected Adults
Laurent, C., Ngom Gueye, N. F., Ndour, C. T., Gueye, P. M., Diouf, M., Diakhat??, N., Tour?? Kane, N. C., Lani??ce, I., Ndir, A., Vergne, L., et al. (2005) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00126334-200501010-00003 · Cited by 160
Evaluation of antiretroviral therapy results in a resource‐poor setting in Blantyre, Malawi
van Oosterhout, J. J., Bodasing, N., Kumwenda, J. J., Nyirenda, C., Mallewa, J., Cleary, P. R., de Baar, M. P., Schuurman, R., Burger, D. M., & Zijlstra, E. E. (2005) · Tropical Medicine & International Health · doi:10.1111/j.1365-3156.2005.01409.x · Cited by 149
Spacek, L. A., Shihab, H. M., Kamya, M. R., Mwesigire, D. M., Ronald, A., Mayanja‐Kizza, H., Moore, R. D., Bates, M. P., & Quinn, T. C. (2005) · Clinical Infectious Diseases · doi:10.1086/499044 · Cited by 115
Self-citationIs average adherence to HIV antiretroviral therapy enough?
Bangsberg, D. R., & Deeks, S. G. (2002) · Journal of General Internal Medicine · doi:10.1046/j.1525-1497.2002.20812.x · Cited by 92
Self-citationElectronic monitoring: Adherence assessment or intervention?
Wagner, G. J., & Ghosh‐Dastidar, B. (2002) · HIV Clinical Trials · doi:10.1310/xgxu-fudk-a9qt-mptf · Cited by 75
Crane, J. T., Kawuma, A., Oyugi, J. H., et al. (2006) · AIDS and Behavior · doi:10.1007/s10461-006-9080-z · Cited by 75
Self-citationAdherence without access to antiretroviral therapy in sub-Saharan Africa?
Bangsberg, D. R., Ware, N. C., & Simoni, J. M. (2005) · AIDS · doi:10.1097/01.aids.0000196168.50303.31 · Cited by 37
Self-citation
Cited by
Pop-Eleches, C., Thirumurthy, H., Habyarimana, J. P., Zivin, J. G., Goldstein, M. P., de Walque, D., MacKeen, L., Haberer, J., Kimaiyo, S., Sidle, J., et al. (2011) · AIDS · doi:10.1097/qad.0b013e32834380c1 · Cited by 982
“These weekly reminders were also effective at reducing the frequency of treatment interruptions, which have been shown to be an important cause of treatment resistant failure in resource-limited settings [29].”
BackgroundSelf-citationConceptual framework for understanding the bidirectional links between food insecurity and HIV/AIDS
Weiser, S. D., Young, S. L., Cohen, C. R., Kushel, M. B., Tsai, A. C., Tien, P. C., Hatcher, A. M., Frongillo, E. A., & Bangsberg, D. R. (2011) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.111.012070 · Cited by 449
Self-citationExplaining Adherence Success in Sub-Saharan Africa: An Ethnographic Study
Ware, N. C., Idoko, J., Kaaya, S., Biraro, I. A., Wyatt, M. A., Agbaji, O., Chalamilla, G., & Bangsberg, D. R. (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000011 · Cited by 437
Self-citationLangebeek, N., Gisolf, E. H., REISS, P. C., Vervoort, S. C. J. M., Hafsteinsdøttir, T. B., Richter, C., Sprangers, M. A. G., & Nieuwkerk, P. T. (2014) · BMC Medicine · doi:10.1186/preaccept-1453408941291432 · Cited by 405
Langebeek, N., Gisolf, E. H., Reiss, P., Vervoort, S. C., Hafsteinsdóttir, T. B., Richter, C., Sprangers, M. A., & Nieuwkerk, P. T. (2014) · BMC Medicine · doi:10.1186/s12916-014-0142-1 · Cited by 394
Metadata
- Authors
- Oyugi, J. H., Byakika-Tusiime, J., Ragland, K., Laeyendecker, O., Mugerwa, R., Kityo, C., Mugyenyi, P., Quinn, T. C., & Bangsberg, D. R.
- Venue
- AIDS
- Published
- 2007-05-11
- Volume
- 21
- Issue
- 8
- Pages
- 965-971
- ISSN
- 0269-9370 (ISSN-L)
- OpenAlex
- W2054022938
- Cited by
- 263
- References
- 29
- FWCI
- 16.65
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.